• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脆性X综合征产前携带者筛查的经济学评估

Economic evaluation of prenatal carrier screening for fragile X syndrome.

作者信息

Vintzileos A M, Ananth C V, Fisher A J, Smulian J C, Day-Salvatore D, Beazoglou T, Knuppel R A

机构信息

Department of Obstetrics and Gynecology and Reproductive Sciences, UMDNJ-Robert Wood Johnson Medical School, New Brunswick, New Jersey, USA.

出版信息

J Matern Fetal Med. 1999 Jul-Aug;8(4):168-72. doi: 10.1002/(SICI)1520-6661(199907/08)8:4<168::AID-MFM6>3.0.CO;2-K.

DOI:10.1002/(SICI)1520-6661(199907/08)8:4<168::AID-MFM6>3.0.CO;2-K
PMID:10406300
Abstract

OBJECTIVE

The objective of this study was to conduct an economic evaluation of routine prenatal carrier testing for fragile X syndrome.

METHODS

This economic analysis was conducted from the societal perspective. A cost-benefit equation was developed based on the premise that the cost of routinely offering prenatal carrier testing for fragile X syndrome should be at least equal to, or less than, the cost of the current practice of not offering such testing. Sensitivity analyses included key assumptions regarding therapeutic abortion rates (50-100%) and patient screening acceptance rates (50-80%).

RESULTS

A policy of routinely offering prenatal carrier testing for fragile X syndrome may be beneficial only if the cost per screening test is less than $120 during the first year of the screening program, or less than $240 when the program reaches its full maturity. Given the current cost per screening test of $250, prenatal screening for carrier status for fragile X syndrome carries the potential for annual losses of approximately $10 to $195 million in the United States. In addition, approximately 46-115 fetal lives may be lost due to invasive genetic procedures.

CONCLUSIONS

Prenatal screening for fragile X syndrome may be economically beneficial only if the cost of the prenatal screening test for carrier identification is considerably less than the current cost.

摘要

目的

本研究的目的是对脆性X综合征的常规产前携带者检测进行经济评估。

方法

本经济分析从社会角度进行。基于常规提供脆性X综合征产前携带者检测的成本应至少等于或低于当前不提供此类检测做法的成本这一前提,建立了成本效益方程。敏感性分析包括关于治疗性流产率(50 - 100%)和患者筛查接受率(50 - 80%)的关键假设。

结果

仅当筛查项目第一年每项筛查测试成本低于120美元,或项目完全成熟时低于240美元时,常规提供脆性X综合征产前携带者检测的政策才可能有益。鉴于目前每项筛查测试成本为250美元,在美国,对脆性X综合征携带者状态进行产前筛查每年可能造成约1000万至1.95亿美元的损失。此外,由于侵入性基因检测程序,可能会导致约46 - 115条胎儿生命丧失。

结论

仅当用于携带者识别的产前筛查测试成本远低于当前成本时,对脆性X综合征进行产前筛查在经济上才可能有益。

相似文献

1
Economic evaluation of prenatal carrier screening for fragile X syndrome.脆性X综合征产前携带者筛查的经济学评估
J Matern Fetal Med. 1999 Jul-Aug;8(4):168-72. doi: 10.1002/(SICI)1520-6661(199907/08)8:4<168::AID-MFM6>3.0.CO;2-K.
2
Cost-effectiveness analysis of prenatal population-based fragile X carrier screening.基于人群的产前脆性X携带者筛查的成本效益分析。
Am J Obstet Gynecol. 2005 Jun;192(6):1905-12; discussion 1912-5. doi: 10.1016/j.ajog.2005.02.052.
3
The cost-effectiveness of prenatal carrier screening for cystic fibrosis.囊性纤维化产前携带者筛查的成本效益
Obstet Gynecol. 1994 Dec;84(6):903-12.
4
Prenatal diagnosis and carrier screening for fragile X by PCR.通过聚合酶链反应(PCR)进行脆性X综合征的产前诊断和携带者筛查。
Am J Med Genet. 1996 Jul 12;64(1):191-5. doi: 10.1002/(SICI)1096-8628(19960712)64:1<191::AID-AJMG34>3.0.CO;2-G.
5
Economic evaluation of prenatal population screening for fragile X syndrome.脆性X综合征产前人群筛查的经济学评估。
Community Genet. 2005;8(2):68-72. doi: 10.1159/000084773.
6
Screening for fragile X syndrome.脆性X综合征筛查
Health Technol Assess. 1997;1(4):i-iv, 1-71.
7
First- and second-trimester evaluation of risk for Down syndrome.孕早期和孕中期唐氏综合征风险评估
Obstet Gynecol. 2007 Jul;110(1):10-7. doi: 10.1097/01.AOG.0000263470.89007.e3.
8
Molecular fragile X screening in normal populations.
Am J Med Genet. 1996 Jul 12;64(1):181-3. doi: 10.1002/(SICI)1096-8628(19960712)64:1<181::AID-AJMG31>3.0.CO;2-H.
9
Preconceptional and prenatal screening for fragile X syndrome: experience with 40,000 tests.脆性X综合征的孕前和产前筛查:40000例检测经验
Prenat Diagn. 2007 Nov;27(11):991-4. doi: 10.1002/pd.1815.
10
Informing policy for the Australian context - Costs, outcomes and cost savings of prenatal carrier screening for cystic fibrosis.为澳大利亚国情提供政策依据——囊性纤维化产前携带者筛查的成本、结果及成本节约情况
Aust N Z J Obstet Gynaecol. 2010 Feb;50(1):51-9. doi: 10.1111/j.1479-828X.2009.01111.x.

引用本文的文献

1
Evaluating Cost-effectiveness of Interventions That Affect Fertility and Childbearing: How Health Effects Are Measured Matters.评估影响生育和生育的干预措施的成本效益:健康影响的衡量方式至关重要。
Med Decis Making. 2015 Oct;35(7):818-46. doi: 10.1177/0272989X15583845. Epub 2015 Apr 29.
2
Pre-conception and antenatal screening for the fragile site on the X-chromosome.X染色体脆性位点的孕前和产前筛查。
Cochrane Database Syst Rev. 2002;2003(1):CD001806. doi: 10.1002/14651858.CD001806.